Medway, MA, United States of America

Roy H Pang


Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Roy H Pang

Introduction

Roy H Pang is a notable inventor based in Medway, Massachusetts. He has made significant contributions to the field of biotechnology, particularly in the development of assays for detecting novel compounds. His work has implications for antiviral research and therapeutic applications.

Latest Patents

Roy H Pang holds a patent for an assay procedure designed to detect and quantify interferon epsilon. This new composition of matter exhibits selective antiviral activity on epithelial cells. The assay involves incubating a preparation believed to contain interferon epsilon with human keratinocyte cells and human fibroblast cells, followed by a virus challenge. The presence of interferon epsilon is indicated if the preparation shows antiviral activity on the keratinocytes but no detectable activity on the fibroblasts. The titer of the preparation can be determined through serial dilution, incubation with keratinocyte subcultures, virus challenge, and viability observation.

Career Highlights

Roy H Pang is associated with Damon Biotech, Inc., where he applies his expertise in biotechnology and assay development. His work at the company has contributed to advancements in the understanding of antiviral mechanisms and therapeutic strategies.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Roy H Pang's innovative work in developing assays for interferon epsilon highlights his contributions to biotechnology and antiviral research. His patent reflects a significant advancement in the detection of antiviral compounds, showcasing the importance of his work in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…